期刊档案 · Multiple
Redox Experimental Medicine
ISSN 2755-158X · Bioscientifica · United Kingdom
Redox Experimental Medicine 中科院新锐版 医学 4区，影响因子 2.5（官网公布），钻石开放获取（无 APC），免版面费，投稿社区反馈审稿约 5 周，2025 年发文 13 篇，ESCI、Scopus 收录，期刊官网显示暂停或关闭投稿。
期刊官网显示暂停或关闭投稿：The journal will close to new submissions on July 1st 2026. 原文 ↗出版商官网 ·
研究范围
研究范围与定位
Redox Experimental Medicine 由 Bioscientifica 出版，属中科院医学大类。按 OpenAlex 近年发文统计，该刊主要发表 Cholesterol and Lipid Metabolism、Adipose Tissue and Metabolism、Exercise and Physiological Responses 等主题的论文，这 3 个主题约占 23.7%。（根据 OpenAlex 主题统计与中科院分区数据生成）
Redox Experimental Medicine is an open-access, peer-reviewed journal publishing redox research that advances our understanding of the effect of redox processes on human health and disease. Alterations in redox processes have a profound impact on the normal physiology of humans, with implications in many diseases. Redox Experimental Medicine will serve as an essential publication for the international scientific community to translate experimental knowledge to redox-based preventative and/or therapeutic interventions, with a view to advancing health. The journal will publish basic and translational articles which have potential therapeutic relevance, as well as pre-clinical and clinical studies. Redox Experimental Medicine will cover all main areas of human pathophysiology, with special but not limited focus on healthy ageing and age-related diseases, cancer, cardiac and circulatory diseases, inflammatory-driven chronic diseases, endocrine and metabolic diseases, pregnancy, perinatal and newborn pathology, neurodegeneration, and infectious diseases. Redox-related nutrition and pharmacology will also be within the scope of the journal. Redox Experimental Medicine will consider for publication all articles which are scientifically sound. We welcome the following article types: research papers (including clinical trials), reviews, brief communications, debates and commentaries. The journal will also publish occasional invited special collections. The journal will accept quality observational studies, following thorough review. REM is currently in its fourth year of publication and has an Impact Factor of 2.1. We aim to achieve indexing in PubMed as soon as possible, after which point all published articles will be indexed retrospectively. The Editorial Board aims to provide rapid and constructive peer review, with a first decision within three weeks. The journal uses a single-blind peer review process.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Multiple
主编 Giuseppe Poli出版商官网
编委会国家分布：未见中国大陆编委；主要国家 美国 6、意大利 6、西班牙 4、英国 3、日本 2（共 36 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Cholesterol and Lipid MetabolismMedicine9.3%
- Adipose Tissue and MetabolismMedicine7.2%
- Exercise and Physiological ResponsesMedicine7.2%
- Muscle Physiology and DisordersBiochemistry, Genetics and Molecular Biology5.2%
- Antioxidant Activity and Oxidative StressMedicine5.2%
- Sirtuins and Resveratrol in MedicineMedicine5.2%
- Redox biology and oxidative stressBiochemistry, Genetics and Molecular Biology5.2%
- Vitamin C and Antioxidants ResearchNursing5.2%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 生化与分子生物学BIOCHEMISTRY & MOLECULAR BIOLOGY | 4 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 4 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusDOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布） 2025
- 2.5出版商官网 ·
- 五年影响因子（出版商公布） 2024
- 3.8出版商官网 ·
- CiteScore 2026-06
- 3.8LetPub ·
- CiteScore（出版商公布） 2025
- 72出版商官网 ·
- SJR 2026-06
- 0.55LetPub ·
- SNIP 2026-06
- 0.38LetPub ·
- h-index
- 9OpenAlex ·
- i10-index
- 7OpenAlex ·
- 两年平均被引
- 1.73OpenAlex ·
- 自引率
- 12.5%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 11LetPub ·
逐年发文量 OpenAlex 统计 · 累计 75 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 8 | 8 | 3 |
| 2025 | 13 | 13 | 26 |
| 2024 | 12 | 12 | 28 |
| 2023 | 20 | 20 | 154 |
| 2022 | 21 | 21 | 169 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度（社区反馈）
- 5 WeeksLetPub ·
- 投稿到发表（期刊自报）
- 约 5 周DOAJ ·
- 评审方式
- 单盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
钻石开放获取（无 APC）DOAJ
所有文章开放获取，且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY、CC BY-NC、CC BY-NC-ND | |
| LetPub | 无文章处理费 | 无 | — | |
| 出版商官网 | 有，金额未公布 | — | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点8 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- ≥ 4 个
- 正文篇幅
- ≤ 5,000 词
- 参考文献格式
- Harvard 格式
- 首次投稿格式
- 允许不按期刊格式排版（free format）
- 图文摘要
- 可选
- 投稿信（Cover letter）
- 可选
- 不接收
- Studies of indeterminate mixtures of natural products
接收的文章类型15 种，含篇幅限制
- brief communicationed for publication under this category. Brief Communications should not exceed 1500 words (not counting the author information, references or legend)正文 ≤ 1,500 词 · 参考文献 ≤ 20
- commentaryCommentaries are typically invited by the Editor-in-Chief, although unsolicited commentaries will be considered. Commentaries are opinion articles that will exa…正文 ≤ 2,500 词
- editorialerences, and have no figures or tables. Editorials All Editorials must be a maximum 1500 words (including references, legends and tables) and 10 reference正文 ≤ 1,500 词 · 参考文献 ≤ 10
- editorialsAll Editorials must be a maximum 1500 words (including references, legends and tables) and 10 references.未说明篇幅
- full articleResearch papers Research paper submissions should be limited to 5000 words. We recommend a maximum of 60 references, with 3–6 figures, illustrations and tables.…未说明篇幅
- hypothesisResearch papers Research paper submissions should be limited to 5000 words. We recommend a maximum of 60 references, with 3–6 figures, illustrations and tables.…未说明篇幅
- letters to the editorblished in Redox Experimental Medicine. Letters to the Editor can be no longer than 1500 words, have no abstract, have no more than three references and h正文 ≤ 1,500 词
- mini reviewxcluding references and figure legends. Mini reviews of approximately 3000 words are acceptable. We recommend a maximum of 60 references for正文 ≤ 3,000 词
- mini reviewsMini reviews of approximately 3000 words are acceptable.未说明篇幅
- perspectiveResearch papers Research paper submissions should be limited to 5000 words. We recommend a maximum of 60 references, with 3–6 figures, illustrations and tables.…未说明篇幅
- research articleative legends: same instructions as for Research articles (see above) Review submissions should be limited to 6000 words, , excluding references and figure lege…正文 ≤ 6,000 词
- research paperResearch papers Research paper submissions should be limited to 5000 words. We recommend a maximum of 60 references, with 3–6 figures, illustrations and tables.…正文 ≤ 5,000 词
- research papersResearch papers Research paper submissions should be limited to 5000 words.未说明篇幅
- reviewThe format of review articles is more fluid but should include the following: 1. Title page Include a separate title page with: Title (maximum 85 characters, in…正文 ≤ 250 词 · 摘要 ≤ 250 词 · 图表 ≤ 6 · 参考文献 ≤ 60
- reviewsReview submissions should be limited to 6000 words, , excluding references and figure legends.未说明篇幅
官网政策摘录利益冲突、数据可用性、许可与版权、开放获取、同行评审、预印本
- 利益冲突 8. Declaration of interest, Funding, Data Availability, Contributions and Acknowledgements
利益冲突声明：所有作者的实际或潜在利益冲突必须完整声明，可声明无冲突或完整披露任何财务或其他潜在利益冲突，包括雇佣与咨询、经费与酬金、持股、版税、专利及董事会成员等。 模型中文摘要
Declaration of interest Actual or perceived conflicts of interest for all authors must be declared in full. Please either (a) declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported; or (b) fully declare any financial or other potential conflict of interest. Conflicts of interest include, but are not limited to: Employment and …
原文 ↗出版商官网 ·- 数据可用性 8. Declaration of interest, Funding, Data Availability, Contributions and Acknowledgements
数据可用性：该摘录要求详细列出研究所涉资金来源，未获资助时须声明本研究未获得任何特定资助。 模型中文摘要
Declaration of interest Actual or perceived conflicts of interest for all authors must be declared in full. Please either (a) declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported; or (b) fully declare any financial or other potential conflict of interest. Conflicts of interest include, but are not limited to: Employment and …
原文 ↗出版商官网 ·- 许可与版权 Licence and Copyright
许可协议：投稿时通讯作者须代表合著者和版权持有者完成出版协议，版权持有者授予Bioscientifica非独占出版许可，版权仍归原版权持有者所有。 模型中文摘要
During the submission process the submitting author will need to complete a publication agreement on behalf of the co-authors and the copyright holder for the article. As part of this agreement, the copyright holder will grant Bioscientifica a non-exclusive licence to publish the article. The copyright is retained by the original copyright holder and is not assigned to Bioscientifica. Authors may …
原文 ↗出版商官网 ·- 开放获取
开放获取：Bioscientifica目前资助文章出版费，所有新投稿的文章出版费将被免除。 模型中文摘要
Bioscientifica is currently sponsoring the Article Publication Charge, and as such the article publishing charges will be waived for all new submissions.
原文 ↗出版商官网 ·- 同行评审
同行评审：投稿由编辑委员会评估并进行外部同行评审，采用单盲方式，评审人和编辑的身份不向作者披露。 模型中文摘要
Submissions are assessed by the Editorial Board and are subject to external peer review using the single anonymous method whereby the identity of the reviewers and editors is not disclosed to authors.
原文 ↗出版商官网 ·- 预印本 Preprint repositories
预印本：Bioscientifica允许将预印本存入认可的存储库（如medRxiv），但须在投稿时告知，且最终发表后作者须在预印本上添加指向已发表文章的链接。 模型中文摘要
A preprint is a version of the article prior to submission to the journal for peer review, and has not been copyedited or typeset. Bioscientifica allows deposition of preprints to recognised repositories, such as medRxiv, provided that Bioscientifica is informed of this at the time of submission and it does not infringe any subsequent copyright or licence agreement. Upon final publication, authors…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Bioscientifica
- 出版国家或地区
- United Kingdom
- 出版语言
- English
- ISSN
- 2755-158X
- 官网最新一期
- Volume 2026, Issue 1（2026 年）
- 官方链接
- 期刊主页 ↗DOAJ
- 投稿系统 ↗出版商官网
- 作者指南 ↗DOAJ
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Redox Experimental Medicine 的常见问题
Redox Experimental Medicine 是中科院几区期刊？
2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Redox Experimental Medicine 的影响因子是多少？
期刊官网公布的影响因子为 2.5（2025 年度），属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 3.8，h-index 为 9。
Redox Experimental Medicine 的审稿周期多长？
投稿社区反馈的平均审稿速度为约 5 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Redox Experimental Medicine 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：≥ 4 个；正文篇幅：≤ 5,000 词；参考文献格式：Harvard 格式；首次投稿格式：允许不按期刊格式排版（free format）；图文摘要：可选；投稿信：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Redox Experimental Medicine 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 36 位编委中，没有中国大陆学者；人数最多的国家是 美国（6 位）、意大利（6 位）、西班牙（4 位）。统计按编委会页面列出的机构国家计，仅供参考。
Redox Experimental Medicine 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Redox Experimental Medicine 被 ESCI、Scopus、DOAJ 收录。
Redox Experimental Medicine 是开放获取期刊吗？版面费多少？
Redox Experimental Medicine 为钻石开放获取（无 APC）。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网、DOAJ；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。